日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CNSC-15. MITOCHONDRIA TRANSFER VIA GLIOMA-ASTROCYTE NETWORK MICROTUBES REPROGRAMS TUMOR CELLS FOR ENHANCED TUMORIGENICITY

CNSC-15. 线粒体通过胶质瘤-星形胶质细胞网络微管转移,重编程肿瘤细胞以增强其致瘤性

Mostaghel, Elahe A; Martin, Paul S; Mongovin, Stephen; Frayo, Shani; Zhang, Ailin; Edlefsen, Kerstin L; Press, Oliver W; Gopal, Ajay K; Watson, Dionysios; Bayik, Defne; Storevik, Simon; Moreino, Shannon; Sprowls, Samuel; Han, Jianhua; Augustsson, Mina; Lauko, Adam; Palavalasa, Sravya; Rosland, Gro; Troike, Katie; Tronstad, Karl; Wang, Sabrina; Sarnow, Katharina; Kay, Kristen; Lunavat, Taral; Silver, Daniel; Dayal, Sahil; Joseph, Justin; Mulkearns-Hubert, Erin; Ystaas, Lars; Deshpande, Gauravi; Guyon, Joris; Zhou, Yadi; Magaut, Capucine; Seder, Juliana; Neises, Laura; Williford, Sarah; Meiser, Johannes; Scott, Andrew J; Sajjakulnukit, Peter; Mears, Jason; Bjerkvig, Rolf; Chakraborty, Abhishek; Daubon, Thomas; Cheng, Feixiong; Iavarone, Antonio; Lyssiotis, Costas; Wahl, Daniel; Hjelmeland, Anita; Hossain, Jubayer; Miletic, Hrvoje; Lathia, Justin

(90)Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma

(90)Y标记的抗CD45抗体异基因造血干细胞移植治疗高危多发性骨髓瘤

Tuazon, Sherilyn A; Sandmaier, Brenda M; Gooley, Theodore A; Fisher, Darrell R; Holmberg, Leona A; Becker, Pamela S; Lundberg, Sally J; Orozco, Johnnie J; Gopal, Ajay K; Till, Brian G; Coffey, David G; Nartea, Margaret E; Matesan, Manuela C; Pagel, John M; Rajendran, Joseph G; Press, Oliver W; Bensinger, William I; Green, Damian J

Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma

钇-90抗CD45免疫疗法联合自体造血干细胞移植治疗复发或难治性淋巴瘤

Tuazon, Sherilyn A; Cassaday, Ryan D; Gooley, Theodore A; Sandmaier, Brenda M; Holmberg, Leona A; Smith, Stephen D; Maloney, David G; Till, Brian G; Martin, Daniel B; Chow, Victor A; Rajendran, Joseph G; Fisher, Darrell R; Matesan, Manuela C; Lundberg, Sally J; Green, Damian J; Pagel, John M; Press, Oliver W; Gopal, Ajay K

Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia

对于复发/难治性白血病或骨髓增生异常综合征患者,可先使用钇-90标记的抗CD45抗体,然后进行低强度造血干细胞移植。

Vo, Phuong; Gooley, Ted A; Rajendran, Joseph G; Fisher, Darrell R; Orozco, Johnnie J; Green, Damian J; Gopal, Ajay K; Haaf, Robyn; Nartea, Margaret; Storb, Rainer; Appelbaum, Frederick R; Press, Oliver W; Pagel, John M; Sandmaier, Brenda M

Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and (90)Y-DOTA

利用靶向 CD45 和 (90)Y-DOTA 的新型双特异性融合蛋白治疗髓系白血病

Orozco, Johnnie J; Kenoyer, Aimee L; Lin, Yukang; O'Steen, Shyril; Guel, Rosario; Nartea, Margaret E; Hernandez, Alexandra H; Hylarides, Mark D; Fisher, Darrell R; Balkin, Ethan R; Hamlin, Donald K; Wilbur, D Scott; Orcutt, Kelly D; Wittrup, K Dane; Green, Damian J; Gopal, Ajay K; Till, Brian G; Sandmaier, Brenda; Press, Oliver W; Pagel, John M

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus (131)I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

在接受 CHOP 联合利妥昔单抗或 CHOP 联合 (131)I-托西莫单抗治疗的既往未接受治疗的滤泡性淋巴瘤患者中,疗效持续良好:III 期随机研究 SWOG-S0016 的长期随访

Shadman, Mazyar; Li, Hongli; Rimsza, Lisa; Leonard, John P; Kaminski, Mark S; Braziel, Rita M; Spier, Catherine M; Gopal, Ajay K; Maloney, David G; Cheson, Bruce D; Dakhil, Shaker; LeBlanc, Michael; Smith, Sonali M; Fisher, Richard I; Friedberg, Jonathan W; Press, Oliver W

R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study

R-CHOP方案、放射免疫疗法和利妥昔单抗维持治疗在未经治疗的滤泡性淋巴瘤中的应用(SWOG S0801):一项单臂、II期、多中心研究

Barr, Paul M; Li, Hongli; Burack, W Richard; LeBlanc, Michael; Smith, Sonali M; Gopal, Ajay K; Floyd, Justin D; Persky, Daniel O; Press, Oliver W; Fisher, Richard I; Friedberg, Jonathan W

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

组织学分级对SWOG S0016滤泡性淋巴瘤队列生存率的影响

Rimsza, Lisa M; Li, Hongli; Braziel, Rita M; Spier, Catherine M; Persky, Daniel O; Dunlap, Jennifer; LeBlanc, Michael; Bartlett, Nancy; Leonard, John P; Smith, Sonali M; Press, Oliver W; Friedberg, Jonathan W

Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial

苯达莫司汀联合利妥昔单抗、依托泊苷和卡铂(T(R)EC)治疗复发或难治性侵袭性淋巴瘤:一项前瞻性多中心1/2期临床试验

Budde, Lihua E; Wu, David; Martin, Daniel B; Philip, Mary; Shustov, Andrei R; Smith, Stephen D; Gooley, Ted A; Chen, Tara L; Libby, Edward N; Chen, Eric Y; Kojouri, Kiarash; Langerak, Alan; Roden, Jennifer E; Press, Oliver W; Gopal, Ajay K

Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions

CD20特异性嵌合抗原受体载体及其培养条件的临床前优化

Lee, Sang Yun; Olsen, Philip; Lee, Dong Hoon; Kenoyer, Aimee L; Budde, Lihua E; O'Steen, Shyril; Green, Damian J; Heimfeld, Shelly; Jensen, Michael C; Riddell, Stanley R; Press, Oliver W; Till, Brian G